QUALITY-BY-DESIGN DEVELOPMENT OF CURCUMIN-LOADED NANOSUSPENSION FOR ENHANCED SOLUBILITY AND SOLIDIFICATION INTO ORAL THIN FILMS

SHOBHA UBGADE; VAISHALI KILOR; NIDHI SAPKAL; SHUBHAM GUPTA; ALOK UBGADE; KRISHNAKANT BHELKAR

doi:10.22159/ijap.2026v18i1.56641

Authors

SHOBHA UBGADE Gurunanak College of Pharmacy, Nagpur-440026, Maharashtra, India
VAISHALI KILOR Gurunanak College of Pharmacy, Nagpur-440026, Maharashtra, India
NIDHI SAPKAL Gurunanak College of Pharmacy, Nagpur-440026, Maharashtra, India
SHUBHAM GUPTA Gurunanak College of Pharmacy, Nagpur-440026, Maharashtra, India
ALOK UBGADE Gurunanak College of Pharmacy, Nagpur-440026, Maharashtra, India
KRISHNAKANT BHELKAR Gurunanak College of Pharmacy, Nagpur-440026, Maharashtra, India

DOI:

https://doi.org/10.22159/ijap.2026v18i1.56641

Keywords:

Curcumin, Nanosuspension, High shear homogenization, Solubility enhancement, Oral thin films

Abstract

Objective:This study aimed to develop and optimize a curcumin (CUR) nanosuspension (NS) to enhance solubility using a Quality-by-Design approach and to solidify the NS into oral thin films (OTFs) as a patient-friendly dosage form.

Methods: NS was prepared using high shear homogenization (HSH). Stabilizer concentration and homogenization time were optimized using a factorial design, with particle size, polydispersity index (PDI), and drug loading defined as critical quality attributes. The optimized NS was characterized forsaturation solubility, in vitro dissolution, and in vivo pharmacokinetics and solidified into OTFs by solvent casting and evaluated.

Results: The optimum stabilizer concentration of SLS (0.7%w/v) and homogenization time (190 mins) resulted in NS witha particle size (259.8±30 nm),PDI (0.402±0.034), drug loading (61±1.1%),15-fold increase in saturation solubility andfaster dissolution. Pharmacokinetic studyrevealed only modest improvement in oral bioavailability of NS (~1.2-fold) higher relative bioavailability as compared to pure drug. OTFs containing NS demonstrated good mechanical integrity, rapid disintegration(26 sec), preservation of nano-sized particles post-solidification (277.8±46 nm) and enhanced dissolution.

Conclusion: A Quality-by-Design-based NS formulation of CUR markedly improved solubility and was successfully solidified into OTFs, offering a stable and convenient oral delivery system.

References

1. Ipar VS, Dsouza A, Devarajan P V. Enhancing Curcumin Oral Bioavailability Through Nanoformulations. Eur J Drug MetabPharmacokinet 2019;44(4):459–80.

2. Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin Drug Deliv 2012;9(11):1347–64.

3. Li X, Uehara S, Sawangrat K, Morishita M, Kusamori K, Katsumi H, et al. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement. Int J Pharm 2018;535(1–2):340–9.

4. Ajay S, Harita D, Tarique M, Amin P. Solubility and dissolution rate enhancement of curcumin using kollidon Va64 by solid dispersion technique. Int J Pharmtech Res 2012;4(3):1055–64.

5. Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. European Journal of Pharmaceutics and Biopharmaceutics 2010;76(3):475–85.

6. Ching YC, Gunathilake TMSU, Chuah CH, Ching KY, Singh R, Liou NS. Curcumin/Tween 20-incorporated cellulose nanoparticles with enhanced curcumin solubility for nano-drug delivery: characterization and in vitro evaluation. Cellulose 2019;26(9):5467–81.

7. Gao Y, Wang C, Sun M, Wang X, Yu A, Li A, et al. In vivo evaluation of curcumin loaded nanosuspensions by oral administration. J Biomed Nanotechnol 2012;8(4):659–68.

8. Ratnatilaka Na Bhuket P, El-Magboub A, Haworth IS, Rojsitthisak P. Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects. Eur J Drug MetabPharmacokinet 2017 Jun 1;42(3):341–53.

9. Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 2014;9(6):304–16.

10. Nangare KA PS, VK K, SR P, SA P. Therapeutics applications of nanosuspension in topical / mucosal drug delivery. Journal of Nanomedicine Research Therapeutics 2018;7(1):1–11.

11. Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. Journal of Controlled Release 2013;172(3):1126–41.

12. Chogale M, Gite S, Patravale V. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study. Drug Dev Ind Pharm 2020;46(11):1763–75.

13. Puglia C, Offerta A, Rizza L, Zingale G, Bonina F, Ronsisvalle S. Optimization of curcumin loaded lipid nanoparticles formulated using high shear homogenizationSH) and ultrasonicationS) methods. J NanosciNanotechnol 2013;13(10):6888–93.

14. Kilor V, Sapkal N, Daud A, Humne S, Gupta T. Development of stable nanosuspension loaded oral films of glimepiride with improved bioavailability. International Journal of Applied Pharmaceutics 2017;9(2):28–33.

15. Pardeshi C V., Rajput P V., Belgamwar VS, Tekade AR, Surana SJ. Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach. Drug Deliv 2013 ;20(1):47–56.

16. Shekhawat P, Pokharkar V. Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment. Int J Pharm 2019;567.

17. Shegokar R, Müller RH. Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399(1–2):129–39.

18. Obeidat WM, Sallam ASA. Evaluation of Tadalafil Nanosuspensions and Their PEG Solid Dispersion Matrices for Enhancing Its Dissolution Properties. AAPS PharmSciTech 2014;15(2):364–74.

19. Hong J, Liu Y, Xiao Y, Yang X, Su W, Zhang M, et al. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation. Drug Deliv 2017;24(1):109–20.

20. Karki S, Kim H, Na SJ, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian J Pharm Sci 2016;11(5):559–74.

21. Chonkar AD, Rao JV, Managuli RS, Mutalik S, Dengale S, Jain P, et al. Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation. European Journal of Pharmaceutics and Biopharmaceutics 2016;103:179–91.

22. Shen B De, Shen CY, Yuan XD, Bai JX, Lv QY, Xu H, et al. Development and characterization of an orodispersible film containing drug nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2013;85(3 PART B):1348–56.

23. Gulsun T, Gursoy RN, Oner L. Design and characterization of nanocrystal formulations containing ezetimibe. Chem Pharm Bull 2011;59(1):41–5.

24. Kaur J, Bawa P, Rajesh SY, Sharma P, Ghai D, Jyoti J, et al. Formulation of curcumin nanosuspension using box-behnken design and study of impact of drying techniques on its powder characteristics. Asian Journal of Pharmaceutical and Clinical Research 2017 ;10(43–51).

25. Oktay AN, Ilbasmis-Tamer S, Karakucuk A, Celebi N. Screening of stabilizing agents to optimize flurbiprofen nanosuspensions using experimental design. J Drug Deliv Sci Technol 2020;57(101690).

26. Sun W, Mao S, Shi Y, Li LC, Fang L. Nanonization of itraconazole by high pressure homogenization: Stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci 2011;100(8):3365–73.

27. Triplett MD, Rathman JF. Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. Journal of Nanoparticle Research 2009;11(3):601–14.

28. Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 2006;312(1–2):179–86.

29. Dhapte V, Kadam V, Pokharkar V. Pyrimethamine nanosuspension with improved bioavailability: In vivo pharmacokinetic studies. Drug Deliv Transl Res 2013;3(5):416–20.

30. Stark B, Pabst G, Prassl R. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure. European Journal of Pharmaceutical Sciences 2010;41(3–4):546–55.

31. Hu J, Ng WK, Dong Y, Shen S, Tan RBH. Continuous and scalable process for water-redispersiblenanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm 2011;404(1–2):198–204.